Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BYAmerican heart journal plus : cardiology research and practice

Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes

  • Mohamed Ibrahim Gbreel1
  • Ahmed Samy Badran2
  • Daniel Robinson3
  • Islam Ebeid4
  • Marwa Hassan5
  • Abdelhakim A. Abdelrahman6
  • Jonas Bodanowitz3
  • Stephan Valenta3
  • Christin Valenta3
  • Plamen Kochev3
  • Jasmin Ortak3
  • Hüseyin Ince3
1 more authors
  • Mahmoud Balata3
6 affiliations
  1. 1Department of Cardiology, General Organization for Teaching Hospitals and Institutions (GOTHI), Cairo, Egypt
  2. 2Faculty of Medicine, Ain Shams University, Cairo, Egypt
  3. 3Department of Cardiology, University Hospital of Rostock, Rostock, Germany
  4. 4Department of Cardiology, National Institute of Diabetes and Endocrinology, Cairo, Egypt
  5. 5Theodor Bilharz Research Institute, Giza, Egypt
  6. 6King's College Hospital, Denmark Hill, London, United Kingdom
Read full textPDFCite

Related

  1. Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention
    Muhammad Haisum Maqsood, Frederick Feit, Upendra Kaul +4
    JAMA CardiologyPeer-reviewedLicence not stated11 citedCardiovascular medicineOpenAlex
  2. Ticagrelor Monotherapy or Aspirin Plus Prasugrel After Percutaneous Coronary Intervention: A Network Meta-Analysis.
    Michele Maremmani, Enrico Citerni, Ovidio De Filippo +7
    JACC. AdvancesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Tocilizumab in Acute Coronary Syndromes: A Systematic Review of Randomized Controlled Trials
    Muhammad Umair Iqbal, Hassan Askari, Ira Abid +3
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes
    Ermilo Echeverria‐Ortegon, Mario César Torres‐Chávez, Alfredo Pérez‐Tagle Tejeda +3
    Clinical cardiologyPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  5. Ticagrelor-Induced Bradyarrhythmias in Acute Coronary Syndrome: A Case Series of Three Patients.
    Ashish Molleti, Ramesh Sankaran, Balakrishnan Vinod Kumar +1
    CureusPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{gbreel2026ticagrelor,
  title = {{Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes}},
  author = {Mohamed Ibrahim Gbreel and Ahmed Samy Badran and Daniel Robinson and Islam Ebeid and Marwa Hassan and Abdelhakim A. Abdelrahman and Jonas Bodanowitz and Stephan Valenta and Christin Valenta and Plamen Kochev and Jasmin Ortak and Hüseyin Ince and Mahmoud Balata},
  journal = {American heart journal plus : cardiology research and practice},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13676095},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Ticagrelor versus prasugrel following PCI in acute coronary syndromes and high-risk coronary artery disease: A meta-analysis of one-year randomized trial outcomes
AU  - Mohamed Ibrahim Gbreel
AU  - Ahmed Samy Badran
AU  - Daniel Robinson
AU  - Islam Ebeid
AU  - Marwa Hassan
AU  - Abdelhakim A. Abdelrahman
AU  - Jonas Bodanowitz
AU  - Stephan Valenta
AU  - Christin Valenta
AU  - Plamen Kochev
AU  - Jasmin Ortak
AU  - Hüseyin Ince
AU  - Mahmoud Balata
PY  - 2026
DA  - 2026/10/05
JO  - American heart journal plus : cardiology research and practice
UR  - https://europepmc.org/article/PMC/PMC13676095
SN  - 2666-6022
ER  -